Boston Scientific Analyst Ratings
Evercore ISI Adjusts Price Target on Boston Scientific to $90 From $82
Evercore Maintains Boston Scientific(BSX.US) With Buy Rating, Raises Target Price to $90
Wells Fargo Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $87
Wells Fargo Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $87
TD Cowen Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $86
BofA Securities Maintains Boston Scientific(BSX.US) With Buy Rating
Piper Sandler Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $90
Analysts' Top Healthcare Picks: TG Therapeutics (TGTX), Boston Scientific (BSX)
Edwards Lifesciences Downgraded at Jefferies on Lower TAVR Growth
Wells Fargo Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $87
Boston Scientific (BSX) Gets a Buy From Wells Fargo
BofA Securities Maintains Boston Scientific(BSX.US) With Buy Rating, Announces Target Price $90
Boston Scientific's Buy Rating: TAVR Developments Signal Market Growth and Revenue Potential
Wells Fargo Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $87
Raymond James Maintains Boston Scientific(BSX.US) With Buy Rating, Raises Target Price to $94
Boston Scientific Is Maintained at Strong Buy by Raymond James
Boston Scientific Analyst Ratings
Citi Maintains Boston Scientific(BSX.US) With Buy Rating, Announces Target Price $92
Barclays Maintains Boston Scientific(BSX.US) With Buy Rating, Raises Target Price to $86